Form 4: Eli Lilly Executive Edgardo Hernandez Reports Stock Transactions
SEC Form 4 Filing
EVP & Pres., Mfg. Operations Edgardo Hernandez reports acquisition and disposal of Eli Lilly & Co stock and restricted stock units on March 1, 2025.
Summary
- On March 1, 2025, Edgardo Hernandez, EVP & Pres., Mfg. Operations of Eli Lilly & Co, reported transactions involving the company's stock.
- Hernandez acquired 2,837 shares of common stock through the exercise of restricted stock units.
- He also disposed of 1,260.325 shares of common stock at a price of $920.63.
- Following these transactions, Hernandez directly owns 39,748.435 shares of Eli Lilly & Co common stock and indirectly owns 867.52 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is a common practice in publicly traded companies to ensure transparency and compliance with securities regulations.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of earliest transaction: acquisition of stock via restricted stock units and disposal of stock. |
| 03/01/2025 | Restricted Stock Unit exercisable and expiration date. |
| 03/03/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.